5e
4
a4
Ophthalmology Home >
e-
5a
- Faculty f
2
28
60
2
63
c
In Memoriam
16
19
1
49
2
13
1b
1d
18
39
2b
28
1d
2 29
1d
25
Samuel G. Jacobson, MD, PhD
78
2b
28
9e
3
64
Director, Center for Hereditary Retinal Degenerations, Scheie Eye Institute, University of Pennsylvania
8f
Director, Retinal Function Department,, Scheie Eye Institute, University of Pennsylvania
11
Department: Ophthalmology
4
1
b
1d
46
Contact information
42
4
3
3
1d
42
Scheie Eye Institute
1c 51 North 39th Street
27 2689
Philadelphia, PA 19104
26
1c 51 North 39th Street
27 2689
Philadelphia, PA 19104
35
f
18
Publications
23 a
3
2
29
23 a
Links
14a Search PubMed for articles
d
4
b
1f
14a Search PubMed for articles
d
13
Education:
21 9 B.A. 17 (Humanities) c
2f University of Illinois, 1966.
21 9 M.D. 15 (Medicine) c
2f University of Illinois, 1970.
21 a Ph.D. 1a (Psychophysics) c
2d University of London, 1977.
c
3
3
21
21 9 B.A. 17 (Humanities) c
2f University of Illinois, 1966.
21 9 M.D. 15 (Medicine) c
2f University of Illinois, 1970.
21 a Ph.D. 1a (Psychophysics) c
2d University of London, 1977.
c
1f
Post-Graduate Training
24 71 Intern, Internal Medicine, Rush-Presbyterian St. Luke's Medical Center, Chicago, IL, 1970-1971.
24 60 Resident, Rush-Presbyterian St. Luke's Medical Center, Chicago, IL, 1971-1972.
24 73 Honorary Clinical Assistant and Doctoral Student, The National Hospital, London, U.K., 1972-1977.
24 6f Resident, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 1977-1980.
24 5e Research Affiliate, MIT, Department of Psychology, Cambridge, MA, 1977-1983.
24 6d Fellow, Moorfields Eye Hospital, Institute of Ophthalmology and Vision Research, 1980-1982.
24 6d Fellow, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 1982-1983.
c
3
3
8a
Permanent link24 71 Intern, Internal Medicine, Rush-Presbyterian St. Luke's Medical Center, Chicago, IL, 1970-1971.
24 60 Resident, Rush-Presbyterian St. Luke's Medical Center, Chicago, IL, 1971-1972.
24 73 Honorary Clinical Assistant and Doctoral Student, The National Hospital, London, U.K., 1972-1977.
24 6f Resident, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 1977-1980.
24 5e Research Affiliate, MIT, Department of Psychology, Cambridge, MA, 1977-1983.
24 6d Fellow, Moorfields Eye Hospital, Institute of Ophthalmology and Vision Research, 1980-1982.
24 6d Fellow, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, 1982-1983.
c
2 29
21
1e
1d
24
2b
29
27
23
7e Semenov EP; Sheplock R; Roman AJ; McGuigan DB; Swider M; Cideciyan AV; Jacobson SG 9a : Reading Performance in Blue Cone Monochromacy: Defining an Outcome Measure for a Clinical Trial. Translational Vision Science & Technology 29 9(13): 13, Dec 2020.
c7 Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS ae : Dose Range Finding Studies with Two RPGR Transgenes in a Canine Model of X-Linked Retinitis Pigmentosa Treated with Subretinal Gene Therapy. Human Gene Therapy 32 31(13-14): 743-755, Jul 2020.
95 Cideciyan AV; Jacobson SG; Roman AJ; Sumaroka A; Wu V; Charng J; Lisi B; Swider M; Aguirre GD; Beltran WA a3 : Rod function deficit in retained photoreceptors of patients with class B Rhodopsin mutations. Scientific Reports 10(1), Jul 2020.
153 Krishnan AK; Jacobson SG; Roman AJ; Iyer BS; Garafalo AV; Heon E; Cideciyan AV: Transient pupillary light reflex in CEP290- or NPHP5-associated Leber congenital amaurosis: Latency as a potential outcome measure of cone function. Vision Research 168: 53-63, Mar 2020.
2d c6 Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA 2 10a : Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized RPGR Delivered by Subretinal Injection in a Canine Model of X-linked Retinitis Pigmentosa. Human Gene Therapy 31(3-4): 253-267, Feb 2020.
1ba Weisschuh N; Sturm M; Baumann B; Audo I; Ayuso C; Bocquet B; Branham K; Brooks BP; Catala-Mora J; Giorda R; Heckenlively JR; Hufnagel RB; Jacobson SG; Kellner U; Kitsiou-Tzeli S; Matet A; Martorell Sampol L; Meunier I; Rudolph G; Sharon D; Stingl K; Streubel B; Varsanyi B; Wissinger B; Kohl S: Deep-intronic variants in CNGB3 cause achromatopsia by pseudoexon activation. Human Mutation 2e 41(1): 255-264, Jan 2020.
af Gardiner KL; Cideciyan AV; Swider M; Dufour VL; Sumaroka A; Komaromy AM; Hauswirth WW; Iwabe S; Jacobson SG; Beltran WA; Aguirre GD 4a : Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy. 79 Molecular Therapy: the Journal of the American Society of Gene Therapy 28(1): 266-278, Jan 2020.
122 Sumaroka A; Cideciyan AV; Sheplock R; Wu V; Kohl S; Wissinger B; Jacobson SG: Foveal Therapy in Blue Cone Monochromacy: Predictions of Visual Potential From Artificial Intelligence. Frontiers in Neuroscience 14, 2020.
1a0 Felden J; Baumann B; Ali M; Audo I; Ayuso C; Bocquet B; Casteels I; Garcia-Sandoval B; Jacobson SG; Jurklies B; Kellner U; Kessel L; Lorenz B; McKibbin M; Meunier I; de Ravel T; Rosenberg T; Ruther K; Vadala M; Wissinger B; Stingl K; Kohl S: Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene. Human Mutation 30 40(8): 1145-1155, Aug 2019.
2c
7
1d
1f
Selected Publications
bc Moreno-Leon L; West EL; O'Hara-Wright M; Li L; Nair R; He J; Anand M; Sahu B; Chavali VRM; Smith AJ; Ali RR; Jacobson SG; Cideciyan AV; Khanna H 7d : RPGR isoform imbalance causes ciliary defects due to exon ORF15 mutations in X-linked retinitis pigmentosa (XLRP). 4e Human Molecular Genetics 29(22): 3706-3716, Jan 2021.7e Semenov EP; Sheplock R; Roman AJ; McGuigan DB; Swider M; Cideciyan AV; Jacobson SG 9a : Reading Performance in Blue Cone Monochromacy: Defining an Outcome Measure for a Clinical Trial. Translational Vision Science & Technology 29 9(13): 13, Dec 2020.
c7 Song C; Dufour VL; Cideciyan AV; Ye GJ; Swider M; Newmark JA; Timmers AM; Robinson PM; Knop DR; Chulay JD; Jacobson SG; Aguirre GD; Beltran WA; Shearman MS ae : Dose Range Finding Studies with Two RPGR Transgenes in a Canine Model of X-Linked Retinitis Pigmentosa Treated with Subretinal Gene Therapy. Human Gene Therapy 32 31(13-14): 743-755, Jul 2020.
95 Cideciyan AV; Jacobson SG; Roman AJ; Sumaroka A; Wu V; Charng J; Lisi B; Swider M; Aguirre GD; Beltran WA a3 : Rod function deficit in retained photoreceptors of patients with class B Rhodopsin mutations. Scientific Reports 10(1), Jul 2020.
153 Krishnan AK; Jacobson SG; Roman AJ; Iyer BS; Garafalo AV; Heon E; Cideciyan AV: Transient pupillary light reflex in CEP290- or NPHP5-associated Leber congenital amaurosis: Latency as a potential outcome measure of cone function. Vision Research 168: 53-63, Mar 2020.
2d c6 Dufour VL; Cideciyan AV; Ye GJ; Song C; Timmers A; Habecker PL; Pan W; Weinstein NM; Swider M; Durham AC; Ying GS; Robinson PM; Jacobson SG; Knop DR; Chulay JD; Shearman MS; Aguirre GD; Beltran WA 2 10a : Toxicity and Efficacy Evaluation of an Adeno-Associated Virus Vector Expressing Codon-Optimized RPGR Delivered by Subretinal Injection in a Canine Model of X-linked Retinitis Pigmentosa. Human Gene Therapy 31(3-4): 253-267, Feb 2020.
1ba Weisschuh N; Sturm M; Baumann B; Audo I; Ayuso C; Bocquet B; Branham K; Brooks BP; Catala-Mora J; Giorda R; Heckenlively JR; Hufnagel RB; Jacobson SG; Kellner U; Kitsiou-Tzeli S; Matet A; Martorell Sampol L; Meunier I; Rudolph G; Sharon D; Stingl K; Streubel B; Varsanyi B; Wissinger B; Kohl S: Deep-intronic variants in CNGB3 cause achromatopsia by pseudoexon activation. Human Mutation 2e 41(1): 255-264, Jan 2020.
af Gardiner KL; Cideciyan AV; Swider M; Dufour VL; Sumaroka A; Komaromy AM; Hauswirth WW; Iwabe S; Jacobson SG; Beltran WA; Aguirre GD 4a : Long-Term Structural Outcomes of Late-Stage RPE65 Gene Therapy. 79 Molecular Therapy: the Journal of the American Society of Gene Therapy 28(1): 266-278, Jan 2020.
122 Sumaroka A; Cideciyan AV; Sheplock R; Wu V; Kohl S; Wissinger B; Jacobson SG: Foveal Therapy in Blue Cone Monochromacy: Predictions of Visual Potential From Artificial Intelligence. Frontiers in Neuroscience 14, 2020.
1a0 Felden J; Baumann B; Ali M; Audo I; Ayuso C; Bocquet B; Casteels I; Garcia-Sandoval B; Jacobson SG; Jurklies B; Kellner U; Kessel L; Lorenz B; McKibbin M; Meunier I; de Ravel T; Rosenberg T; Ruther K; Vadala M; Wissinger B; Stingl K; Kohl S: Mutation spectrum and clinical investigation of achromatopsia patients with mutations in the GNAT2 gene. Human Mutation 30 40(8): 1145-1155, Aug 2019.
2c
